ArticleAging clinical and experimental research2026
Hospital-initiated community pharmacist medication review post-discharge.
Article in Aging clinical and experimental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDrug related problems (DRPs) are commonly encountered by elderly patients on discharge from hospital. Further research is needed into interventions for risk reduction.
aimsTo investigate DRPs post-discharge and assess the Australian hospital-initiated community pharmacist medication review (HIMR) service for benefit.
methodsRetrospective analysis of the Ballina Hospital HIMR service from 20/02/2023 to 20/02/2024 was completed. Data included patients baseline demographics, discharge medications, time to HIMR, DRPs identified, actions taken, and pharmacists' recommendations for medication changes.
resultsThe study cohort (n = 143) had a mean age of 82.2 ± 10.9 years and were prescribed an average of 9.4 ± 4.0 regular medications with 6.0 ± 4.6 medication changes at discharge. The initial HIMR (HIMR1) was completed 7.6 ± 6.1 days (median: 6.0) post-discharge, identifying non-adherence in 43% and possible adverse drug reactions in 22% of patients. Eleven patients (7.7%) received pharmacist interventions of moderate/high significance. Eighty-three follow-up visits (HIMR2) were attended. The HIMR2 reports showed 18.8% of medication change recommendations suggested by the pharmacist at HIMR1 were implemented. DISCUSSION: Significant interventions at HIMR1 were more likely to be experienced by patients ≥ 80 years, when comorbidity increased and when patients were reviewed sooner. Although multiple DRPs were identified, medication change suggestions made at HIMR1 were infrequently actioned in primary care.
conclusionsDRPs and non-adherence were common in the population reviewed. HIMR was valuable for resolving immediate DRPs and assisting medication management, especially when performed nearest discharge. Further optimisation of this service to strengthen engagement with primary care practitioners is recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.